Sera Prognostics (SERA) EBITDA Margin (2020 - 2026)
Sera Prognostics (SERA) reported EBITDA Margin of 61750.0% for Q1 2026, down 4024737.0% on a YoY basis from N/an in Q1 2025, and up 21.71% quarter-over-quarter from 78870.0% in Q4 2025.
Sera Prognostics (SERA) EBITDA Margin (2020 - 2026) Analysis & Trends
Sera Prognostics has reported EBITDA Margin for 7 years, with the latest figure at 61750.0% in Q1 2026.
- For the quarter ending Q1 2026, EBITDA Margin fell 4024737.0% year-over-year to 61750.0%; the trailing twelve-month figure through Mar 2026 stood at 56491.23% (down 2802949.0% YoY), and the FY2025 full-year result was 39167.9%, up 345937.0% from the prior year.
- EBITDA Margin for Q1 2026 stood at 61750.0%, up from 78870.0% in the prior quarter.
- The five-year high for EBITDA Margin was 8745.53% in Q2 2023, with the low at 78870.0% in Q4 2025.
- Historically, EBITDA Margin has averaged 30223.3% across 5 years, with a median of 23537.52% in 2024.
- Annual changes were most pronounced in 2022 — EBITDA Margin soared 3391846 bps — and 2025, when it tumbled 4215750 bps.
- Sera Prognostics' EBITDA Margin stood at 14704.62% in 2022, then retreated by 22 bps to 17868.29% in 2023, then tumbled by 105 bps to 36712.5% in 2024, then tumbled by 115 bps to 78870.0% in 2025, then rose by 22 bps to 61750.0% in 2026.
- The last three EBITDA Margin figures came in at 61750.0% (Q1 2026), 78870.0% (Q4 2025), and 48068.75% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 28.97% |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 10.04% |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 14.52% |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 21.42% |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 19.94% |
| 10 | Sera Prognostics | 100.52 Mn | 100.52 Mn | -28,000.00 | -61,750.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -61,750.00% |
| Dec 31, 2025 | -78,870.00% |
| Sep 30, 2025 | -48,068.75% |
| Jun 30, 2025 | -46,923.53% |
| Mar 31, 2025 | -21,502.63% |
| Dec 31, 2024 | -36,712.50% |
| Sep 30, 2024 | -25,572.41% |
| Jun 30, 2024 | -34,720.83% |
| Dec 31, 2023 | -17,868.29% |
| Sep 30, 2023 | -17,028.57% |
| Jun 30, 2023 | -8,745.53% |
| Mar 31, 2023 | -10,041.00% |
| Dec 31, 2022 | -14,704.62% |
| Sep 30, 2022 | -12,716.09% |
| Jun 30, 2022 | -14,976.92% |
| Mar 31, 2022 | -33,371.05% |
| Dec 31, 2021 | -48,623.08% |
| Sep 30, 2021 | -42,973.91% |
| Jun 30, 2021 | -31,535.00% |
| Mar 31, 2021 | -48,915.38% |